BACKGROUND: The cellular immune response in gastric mucosa infected with Helicobacter pylori is proposed to be predominantly of the T helper cell type 1 type. METHODS: Interleukin (IL)-18, IL-12, and interferon (IFN)-gamma levels were measured in gastric mucosal biopsy specimens by reverse-transcription polymerase chain reaction (PCR) and by enzyme-linked immunosorbent assay; IL18 polymorphisms were determined by PCR. RESULTS: Biopsy specimens from 128 patients (56 with nonulcer dyspepsia, 28 with gastric ulcers, 28 with duodenal ulcers, and 16 with gastric cancer) were examined; 96 patients had H. pylori infection. IL-18 levels were markedly up-regulated in mucosa infected with H. pylori (P < .001), whereas IL-12 and IFN-gamma levels were independent of H. pylori status. IL-18 levels correlated with IFN-gamma levels only in infected patients (R = 0.31 to R = 0.51). IL-18 levels were the determining factor for monocyte infiltration in H. pylori-infected mucosa (P < .001). H. pylori-infected patients displaying IL18 -607C/C and -137G/G had higher IL-18 levels than did those with other genotypes and were more likely to experience treatment failure. CONCLUSION: H. pylori infection induces IL-18 in the gastric mucosa. H. pylori-infected patients with IL18 -607C/C and -137G/G have higher IL-18 levels, which causes severe gastric inflammation. IL18 genotype might be a marker for predicting the effects of eradication therapy.
BACKGROUND: The cellular immune response in gastric mucosa infected with Helicobacter pylori is proposed to be predominantly of the T helper cell type 1 type. METHODS: Interleukin (IL)-18, IL-12, and interferon (IFN)-gamma levels were measured in gastric mucosal biopsy specimens by reverse-transcription polymerase chain reaction (PCR) and by enzyme-linked immunosorbent assay; IL18 polymorphisms were determined by PCR. RESULTS: Biopsy specimens from 128 patients (56 with nonulcer dyspepsia, 28 with gastric ulcers, 28 with duodenal ulcers, and 16 with gastric cancer) were examined; 96 patients had H. pylori infection. IL-18 levels were markedly up-regulated in mucosa infected with H. pylori (P < .001), whereas IL-12 and IFN-gamma levels were independent of H. pylori status. IL-18 levels correlated with IFN-gamma levels only in infected patients (R = 0.31 to R = 0.51). IL-18 levels were the determining factor for monocyte infiltration in H. pylori-infected mucosa (P < .001). H. pylori-infectedpatients displaying IL18 -607C/C and -137G/G had higher IL-18 levels than did those with other genotypes and were more likely to experience treatment failure. CONCLUSION: H. pylori infection induces IL-18 in the gastric mucosa. H. pylori-infectedpatients with IL18 -607C/C and -137G/G have higher IL-18 levels, which causes severe gastric inflammation. IL18 genotype might be a marker for predicting the effects of eradication therapy.
Authors: Adam Kretowski; Katarzyna Mironczuk; Anna Karpinska; Urszula Bojaryn; Maciej Kinalski; Zbigniew Puchalski; Ida Kinalska Journal: Diabetes Date: 2002-11 Impact factor: 9.461
Authors: F Luzza; T Parrello; L Sebkova; L Pensabene; M Imeneo; M Mancuso; A M La Vecchia; G Monteleone; P Strisciuglio; F Pallone Journal: Dig Liver Dis Date: 2001 Jan-Feb Impact factor: 4.088
Authors: B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein Journal: Immunity Date: 2000-11 Impact factor: 31.745
Authors: T Tomita; A M Jackson; N Hida; M Hayat; M F Dixon; T Shimoyama; A T Axon; P A Robinson; J E Crabtree Journal: J Infect Dis Date: 2001-01-24 Impact factor: 5.226
Authors: M T Fera; M Carbone; C Buda; M Aragona; S Panetta; M Giannone; F La Torre; A Giudice; E Losi Journal: Ann N Y Acad Sci Date: 2002-06 Impact factor: 5.691
Authors: Ping I Hsu; Il-Ran Hwang; Diana Cittelly; Kwok-Hung Lai; Hala M T El-Zimaity; Oscar Gutierrez; Jong G Kim; Michael S Osato; David Y Graham; Yoshio Yamaoka Journal: Am J Gastroenterol Date: 2002-09 Impact factor: 10.864
Authors: Rc Sobti; Vl Sharma; Am Abitew; N Berhane; Sa Mahdi; M Askari; Vs Kuttiat; A Wanchu Journal: Balkan J Med Genet Date: 2011-12 Impact factor: 0.519
Authors: Daniel A Leon Rodriguez; F David Carmona; Luis Eduardo Echeverría; Clara Isabel González; Javier Martin Journal: PLoS Negl Trop Dis Date: 2016-03-30
Authors: Paula Keiko Sato; Felipe Delatorre Busser; Flávia Mendes da Cunha Carvalho; Alexandra Gomes Dos Santos; Aya Sadahiro; Constancia Lima Diogo; Adriana Satie Gonçalves Kono; Maria Luiza Moretti; Olinda do Carmo Luiz; Maria Aparecida Shikanai-Yasuda Journal: Front Immunol Date: 2020-10-01 Impact factor: 7.561